Of the six solution weight reduction drugs accessible in the United States, the latest expansion is Saxenda (liraglutide infusion), which entered the commercial center in December 2014. This is what you ought to think about Saxenda, including the discoveries of another post-hoc investigation.
What is Saxenda?
One of the all the more intriguing realities about Saxenda is that it is really a high measurements of the sort 2 diabetes tranquilize called Victoza. As indicated by the Food and Drug Administration, both medications "contain a similar dynamic fixing (liraglutide) at various dosages (3 mg and 1.8 mg, individually)," despite the fact that Saxenda is not recommended for sort 2 diabetes since its wellbeing and viability for diabetes natural appetite suppresent treatment has not been resolved.
Saxenda works by emulating a hormone in the intestinal tract that flags the mind that your stomach is full. The medication is not a silver projectile, be that as it may, but rather an extra treatment alternative to be utilized alongside a lessened calorie eat less carbs and physical work out.
A few different things are of enthusiasm about Saxenda, yet to begin with, we should take a gander at new discoveries concerning the medication.
Does Saxenda work?
The discoveries of a post hoc examination of the three-year section of an extensive trial (Satiety and Clinical Adiposity—Liraglutide Evidence, or SCALE) Obesity and Prediabetes trial were as of late displayed at the European Obesity Summit. Think about members were grown-ups with prediabetes and weight or a BMI of 27 or more noteworthy with hazard variables.